截至2025年9月，蕾特恩在抖音平台累计话题播放量已突破7千万次，内容覆盖祛痘护理、皮肤清洁、面部护理等多重场景。#蕾特恩祛痘 等话题持续升温， 形成了现象级的传播态势。这一切的背后，是蕾特恩强大的中台能力在支撑，有效将公域流量转化为门店的精准客源，确保了新店能够"开业即获客"。 标准赋能：千店连锁实现体验与效率的统一 2025年9月26日抖音举办的"美力共行、耀启新章"丽人年度峰会上，蕾特恩专业祛痘凭借其在数字化经营领域的卓越实践，荣膺"抖音生活服务年度NKA影响 力奖"。这既是行业平台对蕾特恩品牌实力的高度肯定，也标志着其线上线下（300959）深度融合的全域经营模式已成为美业标杆。 在流量红利见顶的当下，抖音生活服务已从重要的"流量场"演进为品牌全域经营的"核心阵地"。蕾特恩积极拥抱变化，将专业祛痘优势与平台生态深度耦 合，系统性地完成了从抓取"流量红利"到构建"模式红利"的关键跨越。 全域经营：构建"内容-种草-引流-转化"增长闭环 蕾特恩并未将抖音视为简单的广告渠道，而是作为与新生代消费者深度沟通的核心阵地。通过品牌矩阵号运营、达人探店、爆款团单打造、品牌自播等组合 策略，蕾特恩成功构建了完整的营销 ...

分红方面，敷尔佳A股上市后累计派现10.00亿元。 机构持仓方面，截止2025年6月30日，敷尔佳十大流通股东中，华宝中证医疗ETF（512170）位居第二 大流通股东，持股254.87万股，相比上期增加65.57万股。南方中证1000ETF（512100）位居第五大流通 股东，持股72.17万股，相比上期增加28.86万股。广发养老指数A（000968）位居第六大流通股东，持 股70.60万股，为新进股东。华夏中证1000ETF（159845）位居第九大流通股东，持股42.27万股，为新 进股东。香港中央结算有限公司退出十大流通股东之列。 资料显示，哈尔滨敷尔佳科技股份有限公司位于黑龙江省哈尔滨市松北区美谷路500号，成立日期2017 年11月28日，上市日期2023年8月1日，公司主营业务涉及从事专业皮肤护理产品的研发、生产和销售的 公司。主营业务收入构成为：化妆品72.39%，医疗器械27.61%。 截至9月19日，敷尔佳股东户数1.50万，较上期减少5.99%；人均流通股5166股，较上期增加6.37%。 2025年1月-6月，敷尔佳实现营业收入8.63亿元，同比减少8.15%；归母净利润2.30亿元 ...

Core Viewpoint - The performance of leading medical beauty companies is diverging amid industry adjustments, with Giant Biological leading in revenue growth while Huaxi Biological and Fulejia face significant declines in performance [2][5][10]. Group 1: Company Performance - Giant Biological reported a revenue of 31.13 billion yuan with a year-on-year growth of 22.5% and a net profit of 11.82 billion yuan, reflecting a 20.2% increase [5][11]. - Huaxi Biological's revenue fell to 22.61 billion yuan, a decrease of 19.57%, with net profit dropping by 35.38% to 2.21 billion yuan [3][4]. - Fulejia's revenue decreased to 8.63 billion yuan, down 8.15%, and net profit fell by 32.54% to 2.3 billion yuan [4][9]. Group 2: Strategic Adjustments - Huaxi Biological attributed its revenue decline to a drop in income from its skin science innovation transformation business, which saw a 33.97% decrease to 9.12 billion yuan [5][7]. - Fulejia's revenue drop was linked to the optimization of offline channels, which impacted sales, while its marketing expenses increased by 39.56% to 4.2 billion yuan [6][10]. - Both companies are undergoing strategic transformations to address their performance issues, with Huaxi Biological implementing significant reforms and Fulejia focusing on improving channel quality [8][10]. Group 3: Industry Trends - The medical beauty industry is shifting from a focus on "traffic dividends" to "technical barriers," with the competition intensifying between hyaluronic acid and recombinant collagen products [2][13]. - The market for recombinant collagen products is projected to grow at a compound annual growth rate of 44.93%, reaching 58.57 billion yuan by 2025 [14]. - Companies are increasingly recognizing the importance of research and development capabilities, patent strategies, and compliance as key competitive factors in the evolving landscape of the medical beauty industry [16].

Group 1 - The core finding of the research indicates that sweat does not form as droplets but rather emerges as a membrane that slowly rises from the pores and gathers on the skin surface, challenging traditional understanding of sweating mechanisms [1] - The study involved six healthy volunteers and utilized specialized clothing with internal water circulation and heating blankets to induce sweating, focusing on the forehead area [1] - The research revealed that sweat first penetrates the outermost layer of the skin (stratum corneum) before accumulating on the skin surface, and when cooling occurs, the sweat film evaporates, leaving a thin layer of salt [1] Group 2 - In a subsequent heating phase, sweat appeared more rapidly due to the salt layer formed during the first sweating phase, which accelerated the penetration of sweat through the stratum corneum, allowing for direct membrane formation on the skin [2] - Understanding the mechanisms of sweat generation can lead to the development of more efficient sweat-wicking materials, functional clothing, and skincare products, providing new insights for temperature regulation and skin health management in extreme heat environments [2]

Company Overview - Fulejia is a company engaged in the research, production, and sales of professional skin care products, with a strong market recognition and brand influence [5] - The company offers a diverse range of products, including medical devices and functional skin care products, covering various forms such as masks, serums, and lotions [5][6] - Fulejia has established a multi-channel sales strategy, combining online platforms like Tmall and Douyin with offline channels such as medical institutions and retail pharmacies [5][6] Financial Performance - In the reporting period, the company achieved operating revenue of 2,016,975,873.58 yuan, representing a year-on-year increase of 4.32% [6] - The net profit attributable to shareholders was 661,129,436.27 yuan, a decrease of 11.77% year-on-year, primarily due to increased sales promotion expenses [6] Business Model - The company employs a "sales-driven production" model to ensure supply-demand balance and cost efficiency [7] - Fulejia utilizes a combination of self-production, entrusted processing, and OEM production to meet market demands [8] - The sales strategy includes direct sales, distribution, and consignment through both online and offline channels [9] Industry Trends - The skin care product manufacturing industry is evolving, with increasing consumer demand for high-quality products [14] - The market for professional skin care products is expected to grow, with projections indicating a market size of 518.5 billion yuan by 2026 [14] Key Performance Drivers - Fulejia focuses on product innovation and marketing strategies to maintain competitiveness in the skin care market [15] - The company has launched various new products to meet diverse consumer needs, including whitening and anti-wrinkle masks [16] - Continuous investment in research and development is aimed at enhancing product supply capabilities and production efficiency [18][19] Research and Development - The company has established a collaborative R&D model, integrating internal and external resources to respond quickly to industry changes [19] - Fulejia has received multiple patents and is actively expanding its product line in medical devices [20]